Development of weighted factors of systemic inflammation based on hematological coefficients in patients with mental disorders

Development of weighted factors of systemic inflammation based on hematological coefficients in patients with mental disorders

 

Authors

 

E.S. Gerasimchuk

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

A.A. Moritz

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

M.V. Ivanov

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

M.Yu. Sorokin

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

N.B. Lutova

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

 

https://doi.org/10.26617/1810-3111-2025-4(129)-13-22

 

Journal: Siberian Herald of Psychiatry and Addiction Psychiatry. 2025; 4 (129):  13-22.

 

Abstract

Background. In recent decades, there has been increasing recognition that mental disorders, from stress-related and affective disorders to schizophrenia spectrum disorders, are associated with a state of low-grade systemic inflammation. A large number of calculated hematological coefficients (CHCs) have been proposed for its assessment, since they are calculated on the basis of a standard complete blood count and are widely available as an adjunct to diagnostic procedures and for stratifying patients based on inflammatory load. However, to identify minimal deviations, simultaneous integration of several indicators may be necessary. The creation of weighted unifying measures can maximize the consideration of information on inflammatory activity and improve the reliability of its assessment. Objective. To develop and evaluate the stability of weighted factors of systemic inflammation based on a set of standard CHCs. Materials. The study involved 185 patients (70 men and 115 women aged 18-72 years) undergoing inpatient treatment at the Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” with diagnoses according to ICD-10: organic, including symptomatic, mental disorders (F0) ‒ n=7, schizophrenia, schizotypal and delusional disorders (F2) ‒ n=127, mood disorders [affective disorders] (F3) ‒ n=39, other mental disorders due to brain damage and dysfunction and to physical disease (F06) ‒ n=12. For each participant, 12 SIHC were calculated based on a complete blood count. Methods. The sample was randomized into training (n=130) and test (n=55) parts. To identify latent factors in the training set, principal component analysis (PCA) was used. Weighted indicators were formed based on factor loadings. To test the reproducibility of the PCA model, a repeated analysis was performed on the test set. The correlation coefficient of the factors was estimated by the Pearson correlation coefficient. Results. The Innate Inflammatory Response factor combined the blood leukocyte shift index according to N.I. Yabluchansky (BLSI), the neutrophil-to-lymphocyte ratio (NLR), and Aggregate Index of Systemic Inflammation (AISI). The Adaptive Immunoreactive Response factor included the immunoreactivity index (IRI) and the lymphocyte-to-monocyte ratio (LMR). The factor structure was reproduced on the test sample (explained variance 64.2%), statistically significant (r=0.95-0.99, p<0.001) correlations between the values of the training and test samples were found. Discussion. The identified factors are consistent with the concept of the dual nature of the immune response in the pathogenesis of mental disorders. The innate inflammatory response factor reflects the acute phase of inflammation and myeloid activity, while the adaptive immunoreactive response factor indicates a specific lymphocytic response associated with the chronic course of the inflammatory process. The results confirm the clinical significance of complex hematological indices for patient stratification and also allow us to consider integrated hematological coefficients as potential markers of neuroinflammatory processes. Conclusion. The study proposes balanced measures for the combined assessment and study of systemic inflammatory processes based on standard hematological coefficients. The analysis revealed a reproducible structure characterizing the two components of the immune response.

 

Keywords: mental disorders, inflammatory markers, hematological tests, biomarkers of neuroinflammation.

 

Article (pdf)

 

Contacts

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Materials  

 

For citation: Gerasimchuk E.S., Moritz A.A., Ivanov M.V., Sorokin M.Yu., Lutova N.B. Development of weighted factors of systemic inflammation based on hematological coefficients in patients with mental disorders. Siberian Herald of Psychiatry and Addiction Psychiatry.2025; 4 (129): 13-22. https://doi.org/10.26617/1810-3111-2025-4(129)-13-22

 

REFERENCES

  1. Moritz AA, Terebova PS, Ivanov MV. The role of immuno-inflammatory factors in the development of negative symptoms in schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(11):42‑48. https://doi.org/10.17116/jnevro202412411142(in Russian).
  2. Ryazantseva UV, Boiko AS, Levchuk LA, Simutkin GG, Ivanova SA, Vasilieva SN, Roshchina OV, Bokhan NA. Relationship between platelet-derived growth factors and clinical and clinical-dynamic characteristics in patients with mood disorders. Siberian Herald of Psychiatry and Addiction Psychiatry. 2024;2(123):5-12. https://doi.org/10.26617/1810-3111-2024-2(123)-5-12(in Russian).
  3. Sălcudean A, Bodo CR, Popovici RA, Cozma MM, Păcurar M, Crăciun RE, Crisan AI, Enatescu VR, Marinescu I, Cimpian DM, Nan AG, Sasu AB, Anculia RC, Strete EG. Neuroinflammation-A crucial factor in the pathophysiology of depression-A comprehensive review. Biomolecules. 2025 Mar 30;15(4):502. https://doi.org/10.3390/biom15040502. PMID: 40305200; PMCID: PMC12024626.
  4. Ravi M, Miller AH, Michopoulos V. The immunology of stress and the impact of inflammation on the brain and behavior. BJPsych Adv. 2021 May;27(Suppl 3):158-165. https://doi.org/10.1192/bja.2020.82. Epub 2021 Mar 5. PMID: 34055387; PMCID: PMC8158089.
  5. LutovaNB,NeznanovNG,ShabelnikAV,GerasimchukES,BocharovaMO,SorokinMYu.Anhedoniainthestructureofpost-COVIDsyndromeinpsychiatricinpatients:theprobableroleofobesity,systemicinflammation,vasculardisregulationandgeneraltherapeuticcomorbidity.V.M.BekhterevReviewofPsychiatryandMedicalPsychology.2024;58(4-2):100-110. https://doi.org/10.31363/2313-7053-2024-1031(in Russian).
  6. Mazza MG, Lucchi S, Rossetti A, Clerici M. Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: A meta-analysis and systematic review. World J Biol Psychiatry. 2020 Jun;21(5):326-338. https://doi.org/10.1080/15622975.2019.1583371. Epub2019 Apr 30. PMID: 30806142.
  7. Gorbunova AP, Rukavishnikov GV, Kasyanov ED, Mazo GE. The role of hematological coefficients of systemic inflammation in the diagnosis and risk assessment of affective disorders. V.M. Bekhterev Review of Psychiatry and Medical Psychology. 2024;58(1):47-55. https://doi.org/10.31363/2313-7053-2024-794(in Russian).
  8. Dionisie V, Filip GA, Manea MC, Movileanu RC, Moisa E, Manea M, Riga S, Ciobanu AM. Neutrophil-to-lymphocyte ratio, a novel inflammatory marker, as a predictor of bipolar type in depressed patients: A quest for biological markers. J Clin Med. 2021 Apr 29;10(9):1924. https://doi.org/10.3390/jcm10091924. PMID: 33946871; PMCID: PMC8125288.
  9. Popov MYu, Popov YuV, Kosterin DN, Lepik OV. Hematological coefficients of inflammation in mental disorders in adolescence: a review of the subject field. Consortium Psychiatricum. 2024;5(2):45-61.https://doi.org/10.17816/CP15514 (in Russian).
  10. Yontar G, Mutlu EA. Neutrophil-to-lymphocyte, platelet-to-lymphocyte ratios and systemic immune-inflammation index in patients with post-traumatic stress disorder. BMC Psychiatry. 2024 Dec 31;24(1):966. https://doi.org/10.1186/s12888-024-06439-y. PMID: 39741243; PMCID: PMC11686920.
  11. Akaishi T, Nakaya K, Nakaya N, Kogure M, Hatanaka R, Chiba I, Tokioka S, Nagaie S, Ogishima S, Hozawa A. Low hemoglobin level and elevated inflammatory hematological ratios associated with depression and sleep disturbance. Cureus. 2024 Mar 21;16(3):e56621. https://doi.org/10.7759/cureus.56621. PMID: 38646220; PMCID: PMC11031807.
  12. Memic-Serdarevic A, Burnazovic-Ristic L, Sulejmanpasic G, Tahirovic A, Valjevac A, Lazovic E. Review of standard laboratory blood parameters in patients with schizophrenia and bipolar disorder. Med Arch. 2020 Oct;74(5):374-380. https://doi.org/10.5455/medarh.2020.74.374-380. PMID:33424093; PMCID: PMC7780782.
  13. Olcina Rodríguez JF, Díaz Fernández J, Orta Mira N, López-Briz E, Gómez-Pajares F. Neutrophil/lymphocyte ratio: Can a non-specific marker of inflammation helps to confirm the inflammatory hypothesis of the serious mental diseases? A case-control study. Med Hypotheses. 2019 Sep;130:109279. https://doi.org/10.1016/j.mehy.2019.109279.Epub 2019 Jun 15. PMID: 31383340.
  14. Šagud M, Madžarac Z, Nedic Erjavec G, Šimunović Filipčić I, Mikulić FL, Rogić D, Bradaš Z, Bajs Janović M, Pivac N. The associations of neutrophil-lymphocyte, platelet-lymphocyte, monocyte-lymphocyte ratios and immune-inflammation index with negative symptoms in patients with schizophrenia. Biomolecules. 2023 Feb 4;13(2):297. https://doi.org/10.3390/biom13020297. PMID: 36830666; PMCID: PMC9952992.
  15. Mert DG, Terzi H. Mean platelet volume in bipolar disorder: the search for an ideal biomarker. Neuropsychiatr Dis Treat. 2016 Aug 16;12:2057-62. https://doi.org/10.2147/NDT.S112374. PMID: 27578978; PMCID: PMC4998027.
  16. Netea MG, Schlitzer A, Placek K, Joosten LAB, Schultze JL. Innate and adaptive immune memory: an evolutionary continuum in the host's response to pathogens. Cell Host Microbe. 2019 Jan 9;25(1):13-26. https://doi.org/10.1016/j.chom.2018.12.006. PMID: 30629914.
  17. Kannan M, Ahmad F, Shankar EM. Editorial: Innate immunity: platelets and their interaction with other cellular elements in host defense and disease pathogenesis. Front Immunol. 2023 Sep 28;14:1292316. https://doi.org/10.3389/fimmu.2023.1292316. PMID:37841277; PMCID: PMC10569416.
  18. Davoine F, Lacy P. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol. 2014 Nov 10;5:570. https://doi.org/10.3389/fimmu.2014.00570. PMID: 25426119; PMCID: PMC4225839.
  19. Lowry CA, Smith DG, Siebler PH, Schmidt D, Stamper CE, Hassell JE Jr, Yamashita PS, Fox JH, Reber SO, Brenner LA, Hoisington AJ, Postolache TT, Kinney KA, Marciani D, Hernandez M, Hemmings SM, Malan-Muller S, Wright KP, Knight R, Raison CL, Rook GA. The microbiota, immunoregulation, and mental health: Implications for public health. Curr Environ Health Rep. 2016 Sep;3(3):270-86. https://doi.org/10.1007/s40572-016-0100-5. PMID: 27436048; PMCID: PMC5763918.
  20. Novellino F, Saccà V, Donato A, Zaffino P, Spadea MF, Vismara M, Arcidiacono B, Malara N, Presta I, Donato G. Innate immunity: A common denominator between neurodegenerative and neuropsychiatric diseases. Int J Mol Sci. 2020 Feb 7;21(3):1115. https://doi.org/10.3390/ijms21031115. PMID: 32046139; PMCID: PMC7036760.
  21. Nudel R, Benros ME, Krebs MD, Allesøe RL, Lemvigh CK, Bybjerg-Grauholm J, Børglum AD, Daly MJ, Nordentoft M, Mors O, Hougaard DM, Mortensen PB, Buil A, Werge T, Rasmussen S, Thompson WK. Immunity and mental illness: findings from a Danish population-based immunogenetic study of seven psychiatric and neurodevelopmental disorders. Eur J Hum Genet. 2019 Sep;27(9):1445-1455. https://doi.org/10.1038/s41431-019-0402-9. Epub 2019 Apr 11. Erratum in: Eur J Hum Genet. 2021 Aug;29(8):1316. https://doi.org/10.1038/s41431-020-00772-y. PMID: 30976114; PMCID: PMC6777475.
  22. Pape K, Tamouza R, Leboyer M, Zipp F. Immunoneuropsychiatry ‒ novel perspectives on brain disorders. Nat Rev Neurol. 2019 Jun;15(6):317-328. https://doi.org/10.1038/s41582-019-0174-4. PMID: 30988501.
  23. KornetovaEG, GalkinSA, KornetovAN, IvanovaSA, BokhanNA. Phenotypes of schizophrenia. Siberian Herald of Psychiatry and Addiction Psychiatry. 2025;2(127):15-32. https://doi.org/10.26617/1810-3111-2025-2(127)-15-32 (in Russian).